Sarah J. Cross

ORCID: 0000-0002-6246-3815 · 6 papers in corpus · active 2020-2022

Study types

  • article 6

Condition tags

  • endometriosis 5
  • mesh:D004715 2
  • mesh:D017699 1
article 2022
Impact of endometriosis on women’s life decisions and goal attainment: a cross-sectional survey of members of an online patient community
BMJ open ·doi:10.1136/bmjopen-2021-052765

OBJECTIVES: To examine women's perceptions of endometriosis-associated disease burden and its impact on life decisions and goal attainment. DESIGN: An anonymous online survey was distributed in October 2018 through the social media network …

article 2021
Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis
Current medical research and opinion ·doi:10.1080/03007995.2021.1929896

OBJECTIVE: Inadequate communication about endometriosis symptom burden between women and healthcare providers is a barrier for optimal treatment. This study describes the development of the EndoWheel, a patient-reported assessment tool that…

article 2021
Real-World Effectiveness of Elagolix in Reducing Endometriosis Pain: 6-Month Results from Elagolix Longitudinal Outcomes (LOTUS) Study
·doi:10.1016/j.jmig.2021.09.431
article 2021
Treating Women with Endometriosis-Associated Pain during the COVID-19 Pandemic
·doi:10.1016/j.jmig.2021.09.435
article 2020
Effect of Elagolix in Women with Moderate to Severe Pelvic Tenderness or Induration: Results from Elaris EM-l and EM-II Clinical Trials
·doi:10.1016/j.jmig.2020.08.371
article 2020
PDB58 REAL WORLD EVIDENCE ON THE IMPACT OF ELAGOLIX UTILIZATION ON PAIN SYMPTOMS, TREATMENT PATTERNS AND HEALTH RESOURCE USE AMONG ENDOMETRIOSIS PATIENTS IN THE UNITED STATES
·doi:10.1016/j.jval.2020.04.245